Sample Request

North America Biodefense Market 2020-2030 by Product (Vaccines, Detection Devices, Antibiotics, Masks), Sales Channel, Application (Military, Civilian), and Country: Trend Forecast and Growth Opportunity

SELECT LICENSE:

Published on 01/04/2020| Code: GMD24001| Category: Aerospace & Defense| Total Pages: 103

North America biodefense market is expected to grow by 5.3% annually in the forecast period and reach $10.07 billion by 2030 amid the COVID-19 pandemic.
Highlighted with 25 tables and 37 figures, this 103-page report “North America Biodefense Market 2020-2030 by Product (Vaccines, Detection Devices, Antibiotics, Masks), Sales Channel, Application (Military, Civilian), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America biodefense market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America biodefense market in every aspect of the classification from perspectives of Product, Sales Channel, Application, and Country.
Based on Product, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
Vaccines
• Anthrax
• Smallpox
• Botulism
• Nuclear/Radiation
• E-Bola
• Zika
• Other Vaccines
Biothreat Detection Devices
• Detectors/Triggering Devices
• Assays and Reagents
• Samplers
• Identifiers
Antibiotics
Masks
Other Products
Based on Sales Channel, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
• Online Sales
• Offline Sales
Based on Application, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
• Military
• Civilian
Geographically, the following national/local markets are fully investigated:
• U.S.
• Canada
• Mexico
For each aforementioned country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of key national markets by Product, Sales Channel, and Application over the forecast years is also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in North America biodefense market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Players (this may not be a complete list and extra companies can be added upon request):
Achaogen, Inc.
Alexeter Technologies LLC
Alnylam Pharmaceuticals, Inc.
Altimmune, Inc.
Bavarian Nordic AS
BioFactura, Inc.
Cleveland Biolabs, Inc.
Dynavax Technologies Inc
Dynport Vaccine Company LLC (DVC)
Elusys Therapeutics, Inc.
Emergent BioSolutions Inc
General Dynamics Corp.
GlaxoSmithKline Plc
Ichor Medical Systems
Mediimmune (AstraZeneca)
Nanotherapeutics, Inc.
Ology Bioscience
PathSensors Inc
Pluristem Therapeutics
Sanofi Pasteur Ltd.
SIGA Technologies, Inc.
Soligenix, Inc.
Xoma Corporation
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

1 Introduction 6
1.1 Industry Definition and Research Scope 6
1.1.1 Industry Definition 6
1.1.2 Research Scope 7
1.2 Research Methodology 10
1.2.1 Overview of Market Research Methodology 10
1.2.2 Market Assumption 11
1.2.3 Secondary Data 11
1.2.4 Primary Data 11
1.2.5 Data Filtration and Model Design 13
1.2.6 Market Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16
2 Market Overview and Dynamics 18
2.1 Market Size and Forecast 18
2.2 Major Growth Drivers 19
2.3 Market Restraints and Challenges 22
2.4 Emerging Opportunities and Market Trends 25
2.5 Porter’s Fiver Forces Analysis 29
3 Segmentation of North America Market by Product 33
3.1 Market Overview by Product 33
3.2 Vaccines 35
3.2.1 Anthrax 38
3.2.2 Smallpox 39
3.2.3 Botulism 40
3.2.4 Nuclear/Radiation 41
3.2.5 E-Bola 42
3.2.6 Zika 43
3.2.7 Other Vaccines 44
3.3 Biothreat Detection Devices 45
3.4 Antibiotics 47
3.5 Masks 48
3.6 Other Products 49
4 Segmentation of North America Market by Sales Channel 50
4.1 Market Overview by Sales Channel 50
4.2 Online Sales 52
4.3 Offline Sales 53
5 Segmentation of North America Market by Application 54
5.1 Market Overview by Application 54
5.2 Military 56
5.3 Civilian 57
6 North America Market 2019-2030 by Country 58
6.1 Overview of North America Market 58
6.2 U.S. 61
6.3 Canada 65
6.4 Mexico 67
7 Competitive Landscape 69
7.1 Overview of Key Vendors 69
7.2 New Product Launch, Partnership, Investment, and M&A 72
7.3 Company Profiles 73
Achaogen, Inc. 73
Alexeter Technologies LLC 75
Alnylam Pharmaceuticals, Inc. 76
Altimmune, Inc. 77
Bavarian Nordic AS 78
BioFactura, Inc. 79
Cleveland Biolabs, Inc. 80
Dynavax Technologies Inc 81
Dynport Vaccine Company LLC (DVC) 82
Elusys Therapeutics, Inc. 83
Emergent BioSolutions Inc 84
General Dynamics Corp. 85
GlaxoSmithKline Plc 86
Ichor Medical Systems 87
Mediimmune (AstraZeneca) 88
Nanotherapeutics, Inc. 89
Ology Bioscience 90
PathSensors Inc 91
Pluristem Therapeutics 92
Sanofi Pasteur Ltd. 93
SIGA Technologies, Inc. 94
Soligenix, Inc. 95
Xoma Corporation 96
8 Investing in North America Market: Risk Assessment and Management 97
8.1 Risk Evaluation of North America Market 97
8.2 Critical Success Factors (CSFs) 100
Related Reports and Products 103

Figure 1. Research Method Flow Chart 10
Figure 2. Breakdown of Primary Research 12
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation 14
Figure 4. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030 16
Figure 5. North America Biodefense Market, 2019-2030, $ mn 18
Figure 6. Primary Drivers and Impact Factors of North America Biodefense Market 19
Figure 7. Primary Restraints and Impact Factors of North America Biodefense Market 22
Figure 8. Investment Opportunity Analysis 26
Figure 9. Porter’s Fiver Forces Analysis of North America Biodefense Market 29
Figure 10. Breakdown of North America Biodefense Market by Product, 2019-2030, % of Sales Revenue 33
Figure 11. North America Addressable Market Cap in 2020-2030 by Product, Value ($ mn) and Share (%) 34
Figure 12. North America Biodefense Market: Vaccines, 2019-2030, $ mn 35
Figure 13. North America Biodefense Market: Anthrax, 2019-2030, $ mn 38
Figure 14. North America Biodefense Market: Smallpox, 2019-2030, $ mn 39
Figure 15. North America Biodefense Market: Botulism, 2019-2030, $ mn 40
Figure 16. North America Biodefense Market: Nuclear/Radiation, 2019-2030, $ mn 41
Figure 17. North America Biodefense Market: E-Bola, 2019-2030, $ mn 42
Figure 18. North America Biodefense Market: Zika, 2019-2030, $ mn 43
Figure 19. North America Biodefense Market: Other Vaccines, 2019-2030, $ mn 44
Figure 20. North America Biodefense Market: Biothreat Detection Devices, 2019-2030, $ mn 45
Figure 21. North America Biodefense Market: Antibiotics, 2019-2030, $ mn 47
Figure 22. North America Biodefense Market: Masks, 2019-2030, $ mn 48
Figure 23. North America Biodefense Market: Other Products, 2019-2030, $ mn 49
Figure 24. Breakdown of North America Biodefense Market by Sales Channel, 2019-2030, % of Sales Revenue 50
Figure 25. North America Addressable Market Cap in 2020-2030 by Sales Channel, Value ($ mn) and Share (%) 51
Figure 26. North America Biodefense Market: Online Sales, 2019-2030, $ mn 52
Figure 27. North America Biodefense Market: Offline Sales, 2019-2030, $ mn 53
Figure 28. Breakdown of North America Market by Application, 2019-2030, % of Revenue 54
Figure 29. North America Addressable Market Cap in 2020-2030 by Application, Value ($ mn) and Share (%) 55
Figure 30. North America Biodefense Market: Military, 2019-2030, $ mn 56
Figure 31. North America Biodefense Market: Civilian, 2019-2030, $ mn 57
Figure 32. Breakdown of North America Biodefense Market by Country, 2019 and 2030, % of Revenue 59
Figure 33. Contribution to North America 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%) 60
Figure 34. U.S. Biodefense Market, 2019-2030, $ mn 62
Figure 35. Canada Biodefense Market, 2019-2030, $ mn 65
Figure 36. Biodefense Market in Mexico, 2015-2026, $ mn 67
Figure 37. Growth Stage of North America Biodefense Industry over the Forecast Period 69

Our Clients

BIC
Suntory Holdings
Continental AG
Ernst Klett
felix
IF Logo
ITC logo
jc
KB
KKR
LR
LSC
Mizuno corporation
Prospect
SRG
Sumitomo
Taichin logo
The Cleanest Way
Meat & Livestock Australia Limited
LEK
IFFCO
STTS
Laundry Capital LLC
Chippenhook Corporation
SAB
IJIN
Hooton
Medica
Medalliacne
Shanghai Chenzhu Instrument Co., Ltd.
Sanofi
Kleen Linnebo und Partner GbR
Bond-Pro, Inc.
E&L Faster Food Imports Inc.
Okinawa Institute of Science and Technology

Need Help?

Please fill form below:

Contact Us

99 WALL STREET #2124 NEW YORK, NY 10005